E. Knight

1.9k total citations
12 papers, 821 citations indexed

About

E. Knight is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Epidemiology. According to data from OpenAlex, E. Knight has authored 12 papers receiving a total of 821 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 3 papers in Internal Medicine and 3 papers in Epidemiology. Recurrent topics in E. Knight's work include Atrial Fibrillation Management and Outcomes (5 papers), Venous Thromboembolism Diagnosis and Management (3 papers) and Acute Ischemic Stroke Management (2 papers). E. Knight is often cited by papers focused on Atrial Fibrillation Management and Outcomes (5 papers), Venous Thromboembolism Diagnosis and Management (3 papers) and Acute Ischemic Stroke Management (2 papers). E. Knight collaborates with scholars based in United Kingdom, Spain and United States. E. Knight's co-authors include A J Boakes, B. N. C. Prichard, Paulus Kirchhof, Andrea Rubboli, Felicita Andreotti, Marcel Levi, A. John Camm, Francisco Marı́n, Elaine M. Hylek and Deirdre A. Lane and has published in prestigious journals such as SHILAP Revista de lepidopterología, Medicine & Science in Sports & Exercise and Heart.

In The Last Decade

E. Knight

12 papers receiving 780 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Knight United Kingdom 8 611 188 111 56 56 12 821
Maja Hellfritzsch Denmark 18 311 0.5× 152 0.8× 111 1.0× 99 1.8× 17 0.3× 47 802
Yonghua Jing United States 16 278 0.5× 146 0.8× 58 0.5× 27 0.5× 41 0.7× 46 802
Robert Edson United States 15 352 0.6× 97 0.5× 48 0.4× 192 3.4× 35 0.6× 26 1.0k
Yulia Khodneva United States 17 589 1.0× 42 0.2× 118 1.1× 86 1.5× 32 0.6× 40 1.0k
Marc Pollack United States 16 337 0.6× 42 0.2× 53 0.5× 118 2.1× 49 0.9× 34 946
Miney Paquette Canada 18 1.5k 2.5× 178 0.9× 80 0.7× 61 1.1× 42 0.8× 42 1.7k
Amichai Perlman Israel 18 277 0.5× 82 0.4× 113 1.0× 111 2.0× 25 0.4× 34 1.0k
Michael Ganetsky United States 13 201 0.3× 117 0.6× 58 0.5× 44 0.8× 64 1.1× 23 584
John Birkhead United Kingdom 19 855 1.4× 80 0.4× 68 0.6× 271 4.8× 24 0.4× 41 1.2k
Candice L. Garwood United States 16 246 0.4× 120 0.6× 86 0.8× 66 1.2× 9 0.2× 44 692

Countries citing papers authored by E. Knight

Since Specialization
Citations

This map shows the geographic impact of E. Knight's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Knight with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Knight more than expected).

Fields of papers citing papers by E. Knight

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Knight. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Knight. The network helps show where E. Knight may publish in the future.

Co-authorship network of co-authors of E. Knight

This figure shows the co-authorship network connecting the top 25 collaborators of E. Knight. A scholar is included among the top collaborators of E. Knight based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Knight. E. Knight is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Fitzmaurice, David, Kate Fletcher, Sheila Greenfield, et al.. (2020). Prevention and treatment of venous thromboembolism in hospital and the community: a research programme including the ExACT RCT. SHILAP Revista de lepidopterología. 8(5). 1–104. 1 indexed citations
2.
Cowie, Martín, Stefan D. Anker, John G.F. Cleland, et al.. (2014). Improving Care for Patients with Acute Heart Failure: Before, During and After Hospitalization. ESC Heart Failure. 1(2). 110–145. 238 indexed citations
3.
Cook, Julia, et al.. (2014). The self-esteem of adults diagnosed with attention-deficit/hyperactivity disorder (ADHD): a systematic review of the literature. ADHD Attention Deficit and Hyperactivity Disorders. 6(4). 249–268. 49 indexed citations
5.
Fauchier, Laurent, Elaine M. Hylek, E. Knight, et al.. (2011). Bleeding risk assessment and management in atrial fibrillation patients. Thrombosis and Haemostasis. 106(12). 997–1011.. 195 indexed citations
7.
Kirchhof, Paulus, et al.. (2009). How Can We Avoid a Stroke Crisis? Working Group Report: Stroke Prevention in Patients with Atrial Fibrillation. 4 indexed citations
8.
Lip, Gregory Y.H., et al.. (2007). Oral anticoagulation in atrial fibrillation: A pan-European patient survey. European Journal of Internal Medicine. 18(3). 202–208. 35 indexed citations
9.
Weingand, Kurt W., et al.. (1999). TOPICAL HEAT PROVIDES PAIN RELIEF OF DELAYED ONSET MUSCLE SORENESS OF THE DISTAL QUADRICEPS MUSCLES. Medicine & Science in Sports & Exercise. 31(Supplement). S75–S75. 4 indexed citations
10.
Richards, David, B. N. C. Prichard, A J Boakes, J. Tuckman, & E. Knight. (1977). Pharmacological basis for antihypertensive effects of intravenous labetalol.. Heart. 39(1). 99–106. 70 indexed citations
11.
Richards, Dee, B. N. C. Prichard, A J Boakes, J. Tuckman, & E. Knight. (1977). Pharmacological basis forantihypertensive effects ofintravenous labetalol. 1 indexed citations
12.
Boakes, A J, E. Knight, & B. N. C. Prichard. (1971). Preliminary Studies of the Pharmacological Effects of 5-{1-Hydroxy-2-[(1-Methyl-3-Phenylpropyl) Amino]-Ethyl}Salicylamide (AH 5158) in Man. Clinical Science. 40(4). 18P–19P. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026